Vanessa Zaiatz Bittencourt (Vanessa Zaiatz-Bittencourt)

Years Active: 2021-2023
Publications (10 Years): 6

This page only lists publications with an associated author ORCID identifier.

Publications

Vanessa Zaiatz Bittencourt, Fiona Jones, Miriam Tosetto, Caitriona Scaife, Gerard Cagney, Evan Jones, Glen A Doherty, Elizabeth J Ryan
Butyrate limits human natural killer cell effector function. Scientific reports 13 (1) (2023)
Vanessa Zaiatz Bittencourt, Fiona Jones, Miriam Tosetto, Caitriona Scaife, Gerard Cagney, Evan Jones, Glen A Doherty, Elizabeth J Ryan
Butyrate limits human natural killer cell effector function. Scientific reports 13 (1) (2023)
Vanessa Zaiatz Bittencourt, Fiona Jones, Miriam Tosetto, Caitriona Scaife, Gerard Cagney, Evan Jones, Glen A Doherty, Elizabeth J Ryan
Butyrate limits human natural killer cell effector function. Scientific reports 13 (1) (2023)
Vanessa Zaiatz Bittencourt, Fiona Jones, Glen Doherty, Elizabeth J Ryan
Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease. Inflammatory bowel diseases 27 (10) (2022)
Vanessa Zaiatz Bittencourt, Fiona Jones, Miriam Tosetto, Glen A Doherty, Elizabeth J Ryan
Dysregulation of Metabolic Pathways in Circulating Natural Killer Cells Isolated from Inflammatory Bowel Disease Patients. Journal of Crohn's & colitis 15 (8) (2021)
Nidhi Kedia-Mehta, Laura Tobin, Vanessa Zaiatz Bittencourt, Marta M Pisarska, Conor De Barra, Chloe Choi, Einas Elamin, Donal O'Shea, Clair M Gardiner, David K Finlay, Andrew E Hogan
Cytokine-induced natural killer cell training is dependent on cellular metabolism and is defective in obesity. Blood advances 5 (21) (2021)

Vanessa Zaiatz Bittencourt.css-eqlu8i{font-size:small;padding-left:4px;} (Vanessa Zaiatz-Bittencourt)